Advertisement

Approach to the Patient with Dyspnea

  • Christopher D. Lang
  • Imran N. Chaudhary
Chapter

Abstract

Dyspnea is a common presenting symptom of cardiovascular disease in both the outpatient and inpatient setting. Despite its prevalence, the lack of specificity and variation in language used to describe sensation of shortness of breath, it poses unique diagnostic and management challenges. Often times, understanding of the underlying mechanisms of dyspnea in parallel with a focused history and exam can lead to an initial workup and differential. It is difficult to have one all-encompassing framework for evaluation of dyspnea; however, it is useful to have a general framework from which to proceed. This chapter will cover the general mechanisms of dyspnea as well as the basic workup for possible pulmonary disease causes. The focus will be specifically on dyspnea as it directly relates to diseases of the cardiovascular system.

Keywords

Pulmonary Hypertension Mitral Regurgitation Constrictive Pericarditis Exertional Dyspnea Hepatopulmonary Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med. 1999;159:321.Google Scholar
  2. 2.
    Schwartzstein RM, Simon PM, Weiss JW, Fencl V, Weinberger SE. Breathlessness induced by dissociation between ventilation and chemical drive. Am Rev Respir Dis. 1989;139:1231–7.PubMedGoogle Scholar
  3. 3.
    Schwartzstein RM, Manning HL, Weiss JW, Weinberger SE. Dyspnea: a sensory experience. Lung. 1990;168:185–99.PubMedCrossRefGoogle Scholar
  4. 4.
    O’Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. Am Rev Respir Dis. 1993;148:1351–7.PubMedGoogle Scholar
  5. 5.
    Banzett RB, Lansing RW, Reid MB, Adams L, Brown R. ‘Air hunger’ arising from increased PCO2 in mechanically ventilated quadriplegics. Respir Physiol. 1989;76:53–67.PubMedCrossRefGoogle Scholar
  6. 6.
    Lane R, Cockcroft A, Adams L, Guz A. Arterial saturation and breathlessness in patients with chronic obstructive airways disease. Clin Sci. 1987;72:693–8.PubMedGoogle Scholar
  7. 7.
    Schwartzstein RM, Lahive K, Pope A, et al. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis. 1987;136:58.PubMedCrossRefGoogle Scholar
  8. 8.
    Burki NK, Lee L. Mechanisms of dyspnea. Chest. 2010;138:1196–201.PubMedCrossRefGoogle Scholar
  9. 9.
    Schwartzstein R. Approach to the patient with dyspnea. In UptoDate, Basow, DS (Ed), UpToDate, Waltham, MA 2011.Google Scholar
  10. 10.
    Scano G, Stendardi L, Grazzini M. Understanding dyspnoea by its language. Eur Respir J. 2005;25:380.PubMedCrossRefGoogle Scholar
  11. 11.
    Mahler DA, Harver A, Lentine T, et al. Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care Med. 1996;154:1357.PubMedGoogle Scholar
  12. 12.
    O’Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med. 1997;155:109.PubMedGoogle Scholar
  13. 13.
    Simon PM, Schwartzstein RM, Weiss JW, et al. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis. 1990;142:1009.PubMedGoogle Scholar
  14. 14.
    Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT. Does this dyspneic patient in the emergency department have congestive heart failure? JAMA. 2005;294(15):1944–56.PubMedCrossRefGoogle Scholar
  15. 15.
    Eurman DW, Potash HI, Eyler WR, Paganussi PJ, Beute GH. Chest pain and dyspnea related to “crack” cocaine smoking: value of chest radiography. Radiology. 1989;172(2):459–62.PubMedGoogle Scholar
  16. 16.
    Hosenpud JD, Greenberg BH. Congestive heart failure. 3rd ed. Philadelphia: LWW; 2006.Google Scholar
  17. 17.
    Schneider HG, Lam L, Lokuge A, et al. B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea: a randomized trial. Ann Intern Med. 2009;150:365.PubMedGoogle Scholar
  18. 18.
    Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161.PubMedCrossRefGoogle Scholar
  19. 19.
    Griffin B, Topol E. Manual of cardiovascular medicine. 3rd ed. Philadelphia: LWW; 2009.Google Scholar
  20. 20.
    Messner-Pellenc P, Ximenes C, Brasileiro CF, Mercier J, Grolleau R, Préfaut CG. Cardiopulmonary exercise testing: determinants of dyspnea due to cardiac or pulmonary limitation. Chest. 1994;106:354–60.PubMedCrossRefGoogle Scholar
  21. 21.
    Braunwald E. Heart failure. In: Braunwald E, Fauci AS, Kasper DL, et al., editors. Harrison’s principles of internal medicine. 15th ed. New York: McGraw-Hill; 2001. p. 1318–29.Google Scholar
  22. 22.
    Canto JG, Shlipak MG, Rogers WJ, Malmgren JA, Frederick PD, Lambrew CT, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000;283(24):3223–9.PubMedCrossRefGoogle Scholar
  23. 23.
    George RB. Chest medicine: essentials of pulmonary and critical care medicine. Philadelphia: LWW; 2005. p. 224.Google Scholar
  24. 24.
    Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation. 2001;104(4):429–35.PubMedCrossRefGoogle Scholar
  25. 25.
    Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(1 Suppl):S43–54.PubMedCrossRefGoogle Scholar
  26. 26.
    Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet. 2003;361(9368):1533–44.PubMedCrossRefGoogle Scholar
  27. 27.
    McLaughlin VV, McGoon MD. Pulmonary arterial hypertension. Circulation. 2006;114:1417–31.PubMedCrossRefGoogle Scholar
  28. 28.
    Persson H, Linder-Klingsell E, Eriksson SV, Erhardt L. Heart failure after myocardial infarction: the importance of diastolic dysfunction. A prospective clinical and echocardiographic study. Eur Heart J. 1995;16(4):496–505.PubMedGoogle Scholar
  29. 29.
    Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988;2(8607):349–60.Google Scholar
  30. 30.
    Nakos G, Kitsiouli EI, Lekka ME. Bronchoalveolar lavage alterations in pulmonary embolism. Am J Respir Crit Care Med. 1998;158(5 Pt 1):1504–10.PubMedGoogle Scholar
  31. 31.
    Walker HK, Hall WD, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations. 3rd ed. Boston: Butterworths; 1990.Google Scholar
  32. 32.
    Simel DL, Rennie D. The rational clinical exam. Evidence based clinical diagnosis. 1st ed. New York: McGraw-Hill; 2009.Google Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  1. 1.Department of Internal MedicineUniversity of Rochester Medical CenterRochesterUSA
  2. 2.Department of CardiologyUniversity of Rochester Medical CenterRochesterUSA

Personalised recommendations